Deltex Medical, an AIM listed firm which produces monitoring systems for post-operative patients, has fallen 9% this morning on news of restricted budgets in developed healthcare markets.
Europe's sovereign debt crisis has put significant pressure on government spending delaying or reducing expected sales of Deltex's equipment, which monitors blood flow to give doctors early warnings on a patient's condition.
Deltex saw a major order in the U.S. expected for the end of 2011 postponed into 2012.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
In the U.K the final nine months of the year were £200,000 behind the equivalent period of 2010.
Commenting on the results Deltex's Chairman Nigel Keen blamed the financial crisis for the company's difficulties: "Our revenue mix is being pushed from capital sales towards higher proportions of higher quality recurring revenue streams: we believe we have now absorbed the worst of the ensuing short term revenue loss from this transition."
Over the last 12 months Deltex is still up 19%.
-
FTSE 100 hits record highs – why is it rising and will we see more gains?Advice UK equities have been described as unloved for a long time but as the FTSE 100 hits new highs, we explain if now is the time to buy British.
-
How to invest in copperIt may be time to invest in copper as the red metal appears poised for a big jump. Dominic Frisby looks at what should investors should buy
